Delivery Order SPE2DB22D2007-SPE2DB24FJ5TH
Award Date
9/4/24
Potential Completion Date
9/5/24
Potential Value
$2.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, for the supply of Lidocaine 5% Patches. The contract has a ceiling value of $1,287.86 and a completion date of May 29, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division, valued at $11,370.41, for the supply of 5% lidocaine patches. The contract has an ultimate completion date of September 30, 2024 and is not set-aside. AmerisourceBergen is a major pharmaceutical distributor that provides a wide range of medical commodities, including prescription drugs, vaccines, and medical supplies, to...
The U.S. Defense Logistics Agency (DLA) awarded a $2,175.99 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of Lidocaine 5% patches. The contract has an ultimate completion date of October 17, 2024 and was not set aside for any specific business category. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle...
The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division for the supply of Lidocaine 5% Patches. The contract, valued at $2,509.53, has a period of performance through June 28, 2024. It is a firm-fixed-price contract, without any set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00...
The Defense Logistics Agency (DLA) awarded a $14,121.12 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,057,471 units of Lidocaine 5% patch. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which covers a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs...
The Defense Logistics Agency (DLA) awarded a $1,213.12 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,229,968 units of Lidocaine 5% Patches. This contract has an ultimate completion date of July 24, 2024 and is not set aside. Amerisourcebergen holds significant Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice Federal Bureau of Investigation, valued up to $999,999,999 and...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,217.63, is for the procurement of Lidocaine 5% patches. The contract has an ultimate completion date of June 13, 2024. Amerisourcebergen also holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $6,086.15 delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division. The contract, which has a completion date of September 11, 2024, is for the supply of Lidocaine 5% patches. This delivery order falls under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for a comprehensive range of medical...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $3,840.72 delivery order contract is for the delivery of Lidocaine 5% Patches and has a completion date of October 28, 2024. The contract is a firm fixed-price delivery order with no set-aside requirements, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $2,709.61 to Amerisourcebergen Drug Corp, a subsidiary of the major pharmaceutical distributor Amerisourcebergen Corporation. The contract is for the provision of 4,564,340,251 units of Lidocaine 5% Patch 30s, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Amerisourcebergen Drug Corp, valued up to $999,999,999.00 through...